University Hospital Jena

Jena 7747

3 studies enrolling now · 8 studies all time

What they study most

Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN), Amyotrophic Lateral Sclerosis, Cystic Fibrosis, Invasive Aspergillosis, Invasive Pulmonary Aspergillosis, Lesion in Body Region, MF, Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF

Studies at this site

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) — Completed
• Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS — Stopped early
• An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) — Stopped early
• Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis — Completed
• VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults — Stopped early